Peter Ang - Concepedia

Author

Peter Ang

National Cancer Centre Singapore ORCID

Also Known As

Ang, Peter, P ANG, P Ang, P C S Ang, P. Ang, P.C.S. Ang, Peter Ang, Peter C-S. Ang, Peter C. S. Ang, Peter C.-S. Ang

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

National Cancer Centre Singapore National University of Singapore Singapore General Hospital Duke-NUS Medical School Gleneagles Hospital

About

Peter Ang is an author at National Cancer Centre Singapore specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	531
2	Engineering	2	2	85
3	Health Sciences	1	1	10
4	Public Health	1	1	20
5	Biomedical Engineering	1	1	30

Peter Ang

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families Xin Yang, Goska Leslie, Alicja Doroszuk, Journal of Clinical Oncology	2019	393
Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer Henry Gómez, Dinesh Chandra Doval, Miguel A. Chavez, Journal of Clinical Oncology	2008	340
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors Wan‐Teck Lim, E.H. Tan, Chee‐Keong Toh, Annals of Oncology Solid TumorsMedicinePharmacologyPharmacotherapyAnti-cancer Agent	2009	139
Influence of <i>ABCB1</i> and <i>ABCG2</i> polymorphisms on doxorubicin disposition in Asian breast cancer patients Suman Lal, Zee Wan Wong, Edwin Sandanaraj, Cancer Science	2008	133
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer Swan Swan Leong, Eng Huat Tan, Kam Weng Fong, Journal of Clinical Oncology	2003	126
Novel <i>SLC22A16</i> Polymorphisms and Influence on Doxorubicin Pharmacokinetics in Asian Breast Cancer Patients Suman Lal, Zee Wan Wong, Srinivasa Rao Jada, Pharmacogenomics	2007	92
<i>CBR1</i>and<i>CBR3</i>pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients Suman Lal, Edwin Sandanaraj, Zee Wan Wong, Cancer Science	2008	76
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening Maurice Chan, Shen Ji, Zhen Xuan Yeo, Journal of Molecular Diagnostics	2012	75
Characteristics of Hori naevus: a prospective analysis H. L. Ee, Hioteng Wong, Chee Leok Goh, British Journal of Dermatology	2005	71
<i>PXR</i> Pharmacogenetics: Association of Haplotypes with Hepatic <i>CYP3A4</i> and <i>ABCB1</i> Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients Edwin Sandanaraj, Suman Lal, Viknesvaran Selvarajan, Clinical Cancer Research	2008	69

Page 1